NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Jianjia Medical Technology

Jianjia Medical Technology

Private
HangzhouHealthcare & Life Scienceshttps://jmed.com/

Last Round

Private Equity

Jan 1, 2022

Est. Valuation

$577.37M

Total Funding Raised

$145.06M

Company Overview

Jianjia Medical Technology is a medical technology company that develops surgical robots to enhance joint replacement surgeries by creating surgical plans, assisting in precise operations, and facilitating postoperative evaluations.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

surgical robotorthopedic surgeryjoint replacementrobotic surgeryrobot-assisted surgerysurgical navigationmedical roboticsdental implant surgerymedical devicesurgical precisionmedtechpreoperative planningdigital surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jianjia Medical Technology Comparables

Compare Jianjia Medical Technology with similar companies based on industry and business-model similarity.

Jianjia Medical Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Yuanhua Tech
90%
MicroPort MedBot
86%
TINAVI Medical Technologies
85%

Jianjia Medical Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJan 1, 2022
Series CMay 20, 2021
Series BSep 7, 2020
Series AApr 24, 2020
AngelDec 1, 2018

Jianjia Medical Technology Investors

Notable investors and investment history

Jianjia Medical Technology investors
InvestorRounds
Baidu VenturesSeries B, Series A
LYFE CapitalSeries C
Puhua CapitalAngel
GL VenturesSeries B
Tiger Global ManagementSeries C, Private Equity
SB China CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 7, 2020

    $15M round led by GL Ventures and Fosun Pharma.

  • Apr 24, 2020

    $2.26M round led by Baidu Ventures

Jianjia Medical Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jianjia Medical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jianjia Medical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Year Founded2018
Last FundingJan 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.